Skip to Main Content
Neurology
YSM Home

INFORMATION FOR

John Seibyl, MD

Professor Adjunct

About

Titles

Professor Adjunct

Appointments

Other Departments & Organizations

Education & Training

MD
Case Western Reserve Univ (1986)

Board Certifications

  • Nuclear Medicine

    Certification Organization
    AB of Nuclear Medicine
    Original Certification Date
    1994

  • Psychiatry

    Certification Organization
    AB of Psychiatry & Neurology
    Original Certification Date
    1992

Research

Research at a Glance

Publications Timeline

A big-picture view of John Seibyl's research output by year.
8Publications

Publications

2022

  • 18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy.
    Messerschmidt K, Barthel H, Brendel M, Scherlach C, Hoffmann KT, Rauchmann BS, Rullmann M, Marek K, Villemagne VL, Rumpf JJ, Saur D, Schroeter ML, Schildan A, Patt M, Beyer L, Song M, Palleis C, Katzdobler S, Fietzek UM, Respondek G, Scheifele M, Nitschmann A, Zach C, Barret O, Madonia J, Russell D, Stephens AW, Koglin N, Roeber S, Herms J, Bötzel K, Bartenstein P, Levin J, Seibyl JP, Höglinger G, Classen J, Sabri O. 18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy. Journal Of Nuclear Medicine : Official Publication, Society Of Nuclear Medicine 2022, 63: 1754-1760. PMID: 35422444, DOI: 10.2967/jnumed.121.262854.
    Peer-Reviewed Original Research

2021

  • Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET.
    Song M, Beyer L, Kaiser L, Barthel H, van Eimeren T, Marek K, Nitschmann A, Scheifele M, Palleis C, Respondek G, Kern M, Biechele G, Hammes J, Bischof G, Barbe M, Onur Ö, Jessen F, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Neumaier B, Barret O, Madonia J, Russell DS, Stephens AW, Mueller A, Roeber S, Herms J, Bötzel K, Danek A, Levin J, Classen J, Höglinger GU, Bartenstein P, Villemagne V, Drzezga A, Seibyl J, Sabri O, Boening G, Ziegler S, Brendel M. Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET. Journal Of Cerebral Blood Flow And Metabolism : Official Journal Of The International Society Of Cerebral Blood Flow And Metabolism 2021, 41: 2957-2972. PMID: 34044665, PMCID: PMC8545042, DOI: 10.1177/0271678X211018904.
    Peer-Reviewed Original Research

2020

  • Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury.
    Beyer L, Nitschmann A, Barthel H, van Eimeren T, Unterrainer M, Sauerbeck J, Marek K, Song M, Palleis C, Respondek G, Hammes J, Barbe MT, Onur Ö, Jessen F, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Neumaier B, Barret O, Madonia J, Russell DS, Stephens AW, Roeber S, Herms J, Bötzel K, Levin J, Classen J, Höglinger GU, Bartenstein P, Villemagne V, Drzezga A, Seibyl J, Sabri O, Brendel M. Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury. European Journal Of Nuclear Medicine And Molecular Imaging 2020, 47: 2911-2922. PMID: 32318783, PMCID: PMC7567714, DOI: 10.1007/s00259-020-04788-w.
    Peer-Reviewed Original Research
  • Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
    Brendel M, Barthel H, van Eimeren T, Marek K, Beyer L, Song M, Palleis C, Gehmeyr M, Fietzek U, Respondek G, Sauerbeck J, Nitschmann A, Zach C, Hammes J, Barbe MT, Onur O, Jessen F, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Neumaier B, Barret O, Madonia J, Russell DS, Stephens A, Roeber S, Herms J, Bötzel K, Classen J, Bartenstein P, Villemagne V, Levin J, Höglinger GU, Drzezga A, Seibyl J, Sabri O. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. JAMA Neurology 2020, 77: 1408-1419. PMID: 33165511, PMCID: PMC7341407, DOI: 10.1001/jamaneurol.2020.2526.
    Peer-Reviewed Original Research

2016

2013

2007

2003